Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Zogenix Inc. : Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

05/03/2013 | 08:40am US/Eastern
Conference Call Scheduled for May 9, 2013 at 4:30 pm ET

SAN DIEGO, May 3, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the first quarter ended March 31, 2013, after the market closes on Thursday, May 9, 2013, and will hold a conference call on this day at 4:30 p.m. ET (1:30 p.m. PT), to discuss these financial results and provide a company update.

To access the live webcast please visit the Company's Investor Relations website at ir.zogenix.com, and to participate, please dial (866) 318-8616 (U.S.) or (617) 399-5135 (International); participant passcode: 65838569.

The conference call will be hosted by Chief Executive Officer Roger L. Hawley, President Stephen J. Farr, Ph.D., and Executive Vice President and Chief Financial Officer Ann Rhoads.

A replay of the conference call will be available beginning May 9, 2013 at 6:30 p.m. ET (3:30 p.m. PT) until May 16, 2013, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 23471504. A replay of the webcast will also be accessible on the Investor Relations website for one month, through June 9, 2013.

About Zogenix

Zogenix, Inc. (Nasdaq:ZGNX), with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, Zohydro™ ER (hydrocodone bitartrate), is an oral, extended-release formulation of various strengths of hydrocodone, without acetaminophen, intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER. Zogenix's second investigational product candidate, Relday™, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia; an investigational new drug application was submitted to the FDA in May 2012. For additional information, please visit www.zogenix.com.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Caitlin Cox | The Ruth Group
         646.536.7033 | ccox@theruthgroup.com
Zogenix
distributed by
React to this article
Latest news
Date Title
08:08p SAFARICOM : Airtel Presses for Share of Safaricom's M-Pesa Platform
08:00p METALIKO RESOURCES : Download 01/07/2015 - Kalgoorlie Gold Project Update - 1m RC Drilling Results
07:40p DEPARTMENT OF AGRICULTURE AUSTRALIAN GOVERNMENT : Ag market access priorities receive significant funding boost
07:40p DEPARTMENT OF AGRICULTURE AUSTRALIAN GOVERNMENT : $100 million extra for smarter approaches to farming
07:35p PHSC : Beard takes reins as PHSC leader
07:27p IRC PROPERTIES : secures funding for Binangonan real estate venture
07:25p GUARANTY BANK : Innoson Group, GTBank square up over N30b lawsuit
07:25p SAVILLS : Is the future now looking brighter for beach towns?
07:25p HMT UK HER MAJESTY TREASURY : Tunisia attack: memorial and Service of Remembrance
07:20p PROVEXIS : Placing of shares via Primarybid.com
Latest news
Advertisement
Hot News 
NATERA : Nasdaq: NTRA) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO
UBISENSE : Hit By Contract Delays, To Restructure Operations
OUTSOURCERY : New Debt Facilities from Vodafone
STADIUM : Trading In Line With China Facility Relocation On Track
ATARI : Last E.T. cartridges up for sale on eBay
Most Read News
06:32p FTD : Celebrates Grateful Dead "Fare Thee Well" Tour With Tie-Dyed Roses (Updated With New Images)
07:01p SAUDI BASIC : Tadawul: Multi-investment, media sectors suffer losses
07:25p GUARANTY BANK : Innoson Group, GTBank square up over N30b lawsuit
07:20p PROVEXIS : Placing of shares via Primarybid.com
07:25p SAVILLS : Is the future now looking brighter for beach towns?
Most recommended articles
04:53p Greece votes in referendum with future in euro in doubt
04:53p Greece votes in referendum with future in euro in doubt
02:50p UNITED RUSAL : EU imposes anti-dumping duties on Russian aluminium foil
12:49p EBA chief dismisses rumours over haircuts to Greek deposits
12:10p Despite crisis, few Greeks ready to forgo coffee